Clinical Trial VICCPED1258


Mutations in DICER1 and Related MicroRNA Processing Genes in Dysplasias, Dysontogenic Diseases, Tumors and Other Conditions

Principal Investigator(s)

Adam Esbenshade


  • Protocol No. VICCPED1258
  • Open Date: 09/06/2012
  • Staging: NA
  • Age Group: Both Child and Adult
  • Scope: International
  • Objective: The general hypothesis we plan to test is that germ-line and somatic mutations in DICER1 are associated with a greater range of benign and malignant conditions than is currently ascribed to dysfunction of DICER1.
  • Disease Sites: Pediatric Solid Tumors
  • Therapies: None Specified
  • Drugs: None Specified
  • Participating Institutions: Vanderbilt University
  • Secondary Protocol No: Not Specified



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.